Turing Pharmaceuticals, the
company that drew widespread
condemnation two months ago
when it bought the toxoplasmosis
drug pyrimethamine (Daraprim)
and raised the price by over 5000%,
has reneged on its promise to
lower the drug’s price by Christmas,
instead choosing to drop the price
charged to hospitals and enhancing
support to disadvantaged patients.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Dec 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.